130 Publications (Page 1 of 6)
2023
Data from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks. NAR Cancer
. | Journal Article
 
Supplementary Figure S1 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Supplementary Figure S1 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Supplementary Figure S2 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Supplementary Figure S2 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Supplementary Figure S3 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Supplementary Figure S3 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Supplementary Figure S4 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Supplementary Figure S4 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Supplementary Figure S5 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Supplementary Figure S5 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Supplementary Figure S6 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
Supplementary Figure S6 from Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer
 
The mechanistic role of cardiac glycosides in DNA damage response and repair signaling. Cellular and Molecular Life Sciences
. | Journal Article
2022
Synthesis and Biological Evaluation of Cardiac Glycosides for Cancer Therapy by Targeting the DNA Damage Response. ChemMedChem
2021
OB-Folds and Genome Maintenance: Targeting Protein–DNA Interactions for Cancer Therapy
Par, SuiVaides, SofiaVaides, SofiaVanderVere-Carozza, Pamela SVanderVere-Carozza, Pamela SPawelczak, Katherine SPawelczak, Katherine SStewart, JasonStewart, JasonTurchi, John J and Turchi, John J
Cancers, vol. 13, (no. 13), 2021. | Journal Article
2020
Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A is Mediated by Replication Protein A in Ovarian Cancer
Sriramkumar, ShruthiS, SriramkumarTD, MatthewsMatthews, Timothy D.AH, GhobashiGhobashi, Ahmed H.Miller, Samuel A.SA, MillerVanderVere-Carozza, Pamela S.PS, VanderVere-CarozzaKS, PawelczakPawelczak, Katherine S.Nephew, Kenneth P.KP, NephewJJ, TurchiTurchi, John JO’Hagan, Heather M. and HM, O’Hagan
Molecular Cancer Research, pp. molcanres.0396.2020. | Journal Article
 
Structure-Guided Optimization of Replication Protein A (RPA)–DNA Interaction Inhibitors
Gavande, Navnath SVanderVere-Carozza, Pamela SPawelczak, Katherine SVernon, Tyler LJordan, Matthew R and Turchi, John J
ACS Medicinal Chemistry Letters, 2020-01-09. | Journal Article
2019
Small-Molecule Inhibitor Screen for DNA Repair Proteins
Turchi, John J and VanderVere-Carozza, Pamela S
Methods in molecular biology (Clifton, N.J.), vol. 1999, pp. 217, 2019-00-00. | Journal Article
2018
Abstract 2829: Targeting the DNA damage response and DNA-PK signaling via small molecule Ku inhibitors
Turchi, John JGavande, Navnath SVanderVere-Carozza, Pamela SVernon, Tyler and Pawelczak, Katherine S
Cancer Research, vol. 78, (no. 13 Supplement), pp. 2829, 2018-07-01. | Journal Article
 
Characterization of Thermally Activated Metalloenediyne Cytotoxicity in Human Melanoma Cells
Keller, Eric JKeller, Eric JKeller, Eric JKeller, EricPorter, MeghanPorter, MeghanPorter, MeghanPorter, MeghanGarrett, Joy EGarrett, Joy EGarrett, JoyGarrett, Joy EVarie, MeredithVarie, MeredithVarie, MeredithVarie, MeredithWang, HaiyanWang, HaiyanWang, HaiyanWang, HaiyanPollok, Karen EPollok, KarenPollok, Karen EPollok, Karen ETurchi, John JTurchi, John JTurchi, John JTurchi, JohnZaleski, Jeffrey MZaleski, Jeffrey MZaleski, JeffreyZaleski, Jeffrey MDynlacht, Joseph RDynlacht, Joseph RDynlacht, Joseph R and Dynlacht, Joseph
Radiation research, vol. 190, (no. 2), pp. 116, 2018-08-00. | Journal Article
2017
Abstract 1416: Development of small molecule inhibitors for cancer therapy by targeting RPA and XPA nucleotide excision repair proteins
Gavande, Navnath SVanderVere-Carozza, Pamela SVernon, Tyler LPawelczak, Katherine and Turchi, John J
Cancer Research, vol. 77, (no. 13 Supplement), pp. 1416, 2017-07-01. | Journal Article
 
Abstract B34: Development of novel small molecule inhibitors targeting DNA repair proteins
Pawelczak, Katherine SGavande, NavnathVanderVere-Carozza, Pamela and Turchi, John
Molecular Cancer Research, vol. 15, (no. 4 Supplement), pp. B34, 2017-04-00. | Journal Article
 
Abstract LB-119: Targeting DNA-PK via small molecule inhibitors of the Ku-DNA interaction
Turchi, John JGavande, NavnathVanderVere-Carozza, PamelaVernon, Tyler and Pawelczak, Katherine
Cancer Research, vol. 77, (no. 13 Supplement), pp. LB-119, 2017-07-01. | Journal Article